[Pharmacotherapy in the treatment of obesity].MMW Fortschr Med. 2006 Mar 02; 148(9):36-8.MF
Currently, the substances orlistat and sibutramine are approved drugs for the pharmacotherapy of obesity. Used in combination with increased exercise and dietary measures, both are capable of significantly reducing weight. In the USA and Europe, official approval for the selective cannabinoid receptor antagonist, rimonabant has been applied for.